Cargando…

Vaccinations in patients with multiple sclerosis: a real-world, single-center experience

Vaccines prevent infections in patients with multiple sclerosis (MS). Though recommendations regarding vaccinating patients with MS have been recently published, real-world data regarding vaccines’ planning in patients receiving disease-modifying drugs (DMDs) for MS are missing. Our aim was, therefo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sbragia, Elvira, Olobardi, Dario, Novi, Giovanni, Lapucci, Caterina, Cellerino, Maria, Boffa, Giacomo, Laroni, Alice, Mikulska, Malgorzata, Sticchi, Laura, Inglese, Matilde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Licensed Vaccines – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746513/ https://www.ncbi.nlm.nih.gov/pubmed/35863064 http://dx.doi.org/10.1080/21645515.2022.2099171

Ejemplares similares

Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
por: Cellerino, Maria, et al.
Publicado: (2021)

Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
por: Tazza, F., et al.
Publicado: (2021)

Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS
por: Cellerino, Maria, et al.
Publicado: (2019)

ASVAC2022 : 8(th) Asian Vaccine Conference
por: Galagoda, Geethani C. S., et al.
Publicado: (2023)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
por: Van den Steen, Peter, et al.
Publicado: (2023)

Mumps-specific antibody persistence in children aged 3–7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China
por: Sun, Jinfang, et al.
Publicado: (2023)

Public health impact of herpes zoster vaccination on older adults in Hong Kong
por: Chan, Paul K. S., et al.
Publicado: (2023)

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
por: Sun, Dapeng, et al.
Publicado: (2023)

Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review
por: Knuf, Markus, et al.
Publicado: (2023)

Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis
por: Zhang, Luofei, et al.
Publicado: (2023)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
por: George, Marina, et al.
Publicado: (2023)

Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study
por: Zhang, Zhuoyu, et al.
Publicado: (2023)

Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus
por: Hwang, Ji-Young, et al.
Publicado: (2023)

Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era
por: Ferrari, Cristiana, et al.
Publicado: (2023)

Measles vaccine uptake and COVID-19
por: Daungsupawong, Hinpetch, et al.
Publicado: (2023)

Improving Tdap maternal immunization rate in Saudi Arabia
por: Aldoosari, Agariad, et al.
Publicado: (2023)

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox
por: Tomita, Noriko, et al.
Publicado: (2023)

In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis
por: Cellerino, Maria, et al.
Publicado: (2023)

The world’s largest measles-Rubella vaccination campaign in Pakistan: Time to invest in routine immunization
por: Rana, Muhammad Suleman, et al.
Publicado: (2022)

Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities
por: Lapucci, Caterina, et al.
Publicado: (2023)

The role of disconnection in explaining disability in multiple sclerosis
por: Lapucci, Caterina, et al.
Publicado: (2022)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
por: Lu, Jinmiao, et al.
Publicado: (2022)

Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022)

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines
por: Montalvo Zurbia-Flores, Gerardo, et al.
Publicado: (2021)

The progress of postapproval clinical studies on Sabin IPV
por: Shi, Li, et al.
Publicado: (2021)

Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review
por: MacDonald, Shannon E., et al.
Publicado: (2021)

Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
por: Khan, Sadaf, et al.
Publicado: (2021)

Vaccination in preterm and low birth weight infants in India
por: Soans, Santosh, et al.
Publicado: (2021)

Burden of vaccine-preventable diseases among at-risk adult populations in the US
por: Kolobova, Irina, et al.
Publicado: (2022)

Commentary on the implications of safety and efficacy studies in pediatric patients with administration of human rabies immune globulin (HRIG)?
por: Siegel, Jerry, et al.
Publicado: (2022)

Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’
por: Sahbudak Bal, Zumrut, et al.
Publicado: (2022)

Seroprevalence comparison of different varicella vaccines among Turkish children
por: Choi, BongKyoo, et al.
Publicado: (2022)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
por: Agarwal, Anurag, et al.
Publicado: (2022)

Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis
por: Kitamura, Noriko, et al.
Publicado: (2022)

Letter to the editor: Correspondence on Chinese medical personnel vaccinations
por: Sekhar, Sejal C., et al.
Publicado: (2022)

Available evidence and potential for vaccines for reduction in antibiotic prescriptions
por: Gabutti, Giovanni
Publicado: (2022)

CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
por: Schiavetti, Irene, et al.
Publicado: (2023)

Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy
por: Costantino, Claudio, et al.
Publicado: (2022)

Impact of treatment on cellular immunophenotype in MS: A cross-sectional study
por: Cellerino, Maria, et al.
Publicado: (2020)

Use of M-M-R II outside of the routinely recommended age range – a systematic literature review
por: Pawaskar, Manjiri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_anjbsqfirmrnvonid2dqb740sq